Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2011 Feb 10;31(5):1139–1140. doi: 10.1161/ATVBAHA.110.222158

Fig. 2.

Fig. 2

Control (Cont.) or hyperinsulinemic (12h Ins.) cells were treated without or with Cr3+, AICAR, or DON. (A, C) EM cholesterol, (B) pAMPK, and (D) ApoA1-mediated cholesterol efflux. n = 4-11. *P < 0.05 versus untreated control. (E) Model of Cr3+ protection against (Blue) hyperinsulinemia-induced cholesterol-associated impairment in (Red) Rab8/ABCA1 trafficking and ApoA1-mediated cholesterol efflux.